ARK Investment Management LLC
Institutional investor · Portfolio as of Q4 2022
Top Holdings232 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
EXACT SCIENCES CORP | 16M | $794.2M | 6.9% | $101.30 | -51.12% | 10 qtrssince 2020-Q3 | Decreased 0 |
ZOOM COMMUNICATIONS INC | 10.6M | $719.1M | 6.2% | $213.05 | -68.21% | 9 qtrssince 2020-Q4 | Decreased 0 |
TESLA INC | 4.6M | $569.8M | 4.9% | $216.59 | -43.13% | 17 qtrssince 2018-Q4 | Increased 65 |
BLOCK INC | 9M | $565.8M | 4.9% | $130.62 | -51.89% | 17 qtrssince 2018-Q4 | Decreased 0 |
UIPATH INC | 44.1M | $559.9M | 4.9% | $42.47 | -70.07% | 7 qtrssince 2021-Q2 | Decreased 0 |
ROKU INC | 12.1M | $493.1M | 4.3% | $141.59 | -71.26% | 15 qtrssince 2019-Q2 | Increased 58 |
SHOPIFY INC - CLASS A | 13.3M | $460.9M | 4.0% | $31.79 | +9.18% | 17 qtrssince 2018-Q4 | Decreased 0 |
TELADOC HEALTH INC | 18.9M | $447.7M | 3.9% | $162.86 | -85.48% | 17 qtrssince 2018-Q4 | Decreased 0 |
TWILIO INC - A | 7.4M | $362.8M | 3.1% | $216.80 | -77.42% | 17 qtrssince 2018-Q4 | Increased 62 |
INTELLIA THERAPEUTICS INC | 9.4M | $328.7M | 2.8% | $36.35 | -4.00% | 17 qtrssince 2018-Q4 | Decreased 0 |
COINBASE GLOBAL INC -CLASS A | 9.2M | $325.2M | 2.8% | $170.52 | -79.25% | 7 qtrssince 2021-Q2 | Increased 63 |
BEAM THERAPEUTICS INC | 8.2M | $321.2M | 2.8% | $81.81 | -52.20% | 9 qtrssince 2020-Q4 | Decreased 0 |
CRISPR THERAPEUTICS AG | 7.8M | $318.3M | 2.8% | $77.33 | -47.43% | 17 qtrssince 2018-Q4 | Decreased 0 |
UNITY SOFTWARE INC | 11M | $313.7M | 2.7% | $88.32 | -67.63% | 10 qtrssince 2020-Q3 | Decreased 0 |
DRAFTKINGS INC | 25M | $285.1M | 2.5% | $12.40 | -8.12% | 3 qtrssince 2022-Q2 | Increased 53 |
PAGERDUTY INC | 10.1M | $268.2M | 2.3% | $28.69 | -7.44% | 12 qtrssince 2020-Q1 | Decreased 0 |
Ginkgo Bioworks Holdings, Inc. | 144.4M | $244M | 2.1% | — | — | — | — |
ROBLOX CORP -CLASS A | 8.5M | $240.9M | 2.1% | $53.33 | -46.63% | 8 qtrssince 2021-Q1 | Decreased 0 |
ROBINHOOD MARKETS INC - A | 29.2M | $238.1M | 2.1% | $23.90 | -65.95% | 6 qtrssince 2021-Q3 | Decreased 0 |
PACIFIC BIOSCIENCES CALIF IN | 25.7M | $210.2M | 1.8% | $14.47 | -43.48% | 15 qtrssince 2019-Q2 | Decreased 0 |
ARK Investment Management LLC manages $11.5B across 232 positions as of Q4 2022. Top holdings: EXAS (6.9%), ZM (6.2%), TSLA (4.9%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 5/5.0.
Active quarter - 5 new positions, 8 exits, 61 increased. Top move: TSLA (INCREASED, conviction 65). Portfolio: $11.5B across 232 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer